Perimenopause and menopause mark a significant phase in a woman’s life, often accompanied by challenges such as hormonal imbalances, hot flashes, mood swings, and sleep disturbances. These experiences are particularly acute in India, where women enter menopause earlier than their Western counterparts—at an average age of 46.2 years compared to 51 years globally. Perimenopause, which precedes menopause, often begins around the age of 44.7 and can last up to a decade, bringing with it a wide range of symptoms.
Sanjith Shetty, Founder and CEO of Miror, highlighted the lack of awareness and resources for women in this phase of life. “Perimenopause and menopause bring unique challenges, but they also represent a powerful chapter in a woman’s life. Unfortunately, these experiences are often overlooked, leaving many women to face them without adequate support. With Miror Bliss, we aim to change that by combining science, nature, and a deep understanding of women’s health to empower women to embrace this phase with vitality and resilience,” Shetty said.
Miror Bliss is formulated with 18 scientifically selected ingredients designed to address common symptoms and support holistic health. It targets hormonal balance with ingredients like Shatavari and Black Cohosh while providing relief from hot flashes and night sweats through Evening Primrose and Gokhru. Mood and sleep issues are addressed with Ashwagandha and Magnesium Glycinate, while Calcium and Vitamin D3 strengthen bones and joints, ensuring resilience through these transitions. The inclusion of Ashoka Bark and CoQ10 bridges critical nutritional gaps, providing long-term health benefits.
Hormonal changes and nutrient deficiencies during perimenopause make it difficult for women to meet their nutritional needs through diet alone. Supplements like Miror Bliss offer a practical solution, addressing symptoms while supporting overall health and well-being.
The launch of Miror Bliss aligns with a growing need for targeted wellness solutions in India, where the number of post-menopausal women is projected to rise from 96 million in 2011 to an estimated 401 million by 2026. By addressing these pressing health challenges, Miror continues to lead the way in reshaping how women approach perimenopause and menopause care.